Mednet Logo
HomeQuestion

How do you manage refractory hyponatremia in patients on active therapy in small cell lung cancer?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · The Ohio State University School of Medicine

The classic teaching is that if this is a paraneoplastic SIADH then treat the underlying cancer. If hyponatremia is worsening despite treatment, it might herald progression. I have used tolvaptan in the past as bridge but without effective treatment, this is likely not going to be very effective. Of...

Register or Sign In to see full answer

How do you manage refractory hyponatremia in patients on active therapy in small cell lung cancer? | Mednet